Abstract
Use of biomarkers may help reduce inhaled corticosteroid burden in severe asthma if treatment advice is followed. T2 low asthma is less common than previously thought. https://bit.ly/3rG7SZ2
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
